Fonte: Journal American College of Cardiology. Nome do evento: Annual Scientific Session American College of Cardiology. Unidade: FM
Assuntos: TRANSPLANTE AUTÓLOGO, MEDULA ESPINHAL, ISQUEMIA MIOCARDICA
ABNT
GOWDAK, Luís H. et al. Intramyocardial injection of autologus bone marrow cells improves myocardial perfusion in severe ischemic heart disease: a 30-day assessment. Journal American College of Cardiology. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 05 set. 2024. , 2004APA
Gowdak, L. H., Schettert, I., Vieira, M. C., Rochitte, C. E., Meneghetti, C., Cesar, L. A. M., et al. (2004). Intramyocardial injection of autologus bone marrow cells improves myocardial perfusion in severe ischemic heart disease: a 30-day assessment. Journal American College of Cardiology. New York: Faculdade de Medicina, Universidade de São Paulo.NLM
Gowdak LH, Schettert I, Vieira MC, Rochitte CE, Meneghetti C, Cesar LAM, Chamone D de AF, Krieger JE, Ramires JAF, Oliveira S de A. Intramyocardial injection of autologus bone marrow cells improves myocardial perfusion in severe ischemic heart disease: a 30-day assessment. Journal American College of Cardiology. 2004 ;43 272A.[citado 2024 set. 05 ]Vancouver
Gowdak LH, Schettert I, Vieira MC, Rochitte CE, Meneghetti C, Cesar LAM, Chamone D de AF, Krieger JE, Ramires JAF, Oliveira S de A. Intramyocardial injection of autologus bone marrow cells improves myocardial perfusion in severe ischemic heart disease: a 30-day assessment. Journal American College of Cardiology. 2004 ;43 272A.[citado 2024 set. 05 ]